使用多变量回归,交叉阅读和ML算法对水生生物的纳米颗粒毒性的洞察:大夫尼大和丹尼奥雷里奥的预测模型
1Drug Theoretics and Cheminformatics Laboratory, Department of Pharmaceutical Technology, Jadavpur University, Kolkata, 700032, India.
Aquatic toxicology (Amsterdam, Netherlands)
|October 13, 2024
概括
评估水生环境中的纳米粒子毒性至关重要. 这项研究使用计算模型来识别关键的纳米粒子特征,如大小和组成,这些特征驱动D. magna和斑马鱼的毒性.
科学领域:
- 环境科学 环境科学
- 毒理学 毒理学 毒理学
- 计算化学计算化学
背景情况:
- 纳米粒子 (NP) 在纳米技术中越来越多地使用,引发了人们对它们对环境的影响的担忧,特别是对水生生物,如大夫尼亚大和斑马鱼 (Danio rerio).
- 通过传统的实验来评估每个NP的生态毒性是不切实际的,需要开发替代的in silico方法.
研究的目的:
- 开发和验证用于预测水生环境中金属氧化物纳米粒子 (MeOxNP) 毒性的计算模型.
- 确定MeOxNPs的关键物理化学特征,这些特征会影响它们对D. magna和斑马鱼的毒性.
- 为了比较机器学习和阅读交叉方法的有效性与传统的定量结构-活动关系 (QSAR) 模型.
主要方法:
- 从数据库和文献评论中收集关于MeOxNPs及其对D. magna和斑马鱼的影响的数据.
- 使用多变量回归,横读 (RA) 和机器学习 (ML) 算法开发QSAR模型.
- 利用简单的周期表衍生的描述符来识别驱动纳米毒性的关键特征.
主要成果:
- 纳米粒子大小,金属数量,金属核心环境和氧化状态被确定为D. magna中毒性的关键驱动因素.
- 对于斑马鱼来说,更高的分子量,金属核心和氧气存在影响了酶抑制,这与口延迟相关.
结论:
- 计算模型,包括QSAR和ML,对于预测水中纳米毒性的有效.
- 确定关键的NP特征有助于早期风险评估和更安全的纳米材料的设计.
- 该研究强调了对NP环境风险评估的可转移,可重复和可解释模型的需求.
相关概念视频
01:20Pharmacokinetic Models: Overview
2.6K
Pharmacokinetic models utilize mathematical analysis to achieve a detailed quantitative understanding of a drug's life cycle within the body. They are instrumental in simulating a drug's pharmacokinetic parameters, predicting drug concentrations over time, optimizing dosage regimens, linking concentrations with pharmacologic activity, and estimating potential toxicity.
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
2.6K
01:23Mechanistic Models: Compartment Models in Individual and Population Analysis
359
Mechanistic models are utilized in individual analysis using single-source data, but imperfections arise due to data collection errors, preventing perfect prediction of observed data. The mathematical equation involves known values (Xi), observed concentrations (Ci), measurement errors (εi), model parameters (ϕj), and the related function (ƒi) for i number of values. Different least-squares metrics quantify differences between predicted and observed values. The ordinary least...
359
01:06Model Approaches for Pharmacokinetic Data: Distributed Parameter Models
333
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
333
01:26Pharmacokinetic Models: Comparison and Selection Criterion
488
Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
488
01:23Toxicity Testing in Animals
204
Toxicity tests in animals are grounded on two main assumptions: first, the effects observed in laboratory animals can be extrapolated to humans, especially when adjusted for body surface area; second, high-dose exposure in animals is essential to identify potential human hazards from lower doses. This is based on the quantal dose-response concept, which faces the challenge of extrapolating results from relatively few test animals to much larger human populations. For example, a 0.01% incidence...
204